Specialty Pharmacy

Investigational drugs shut down critical genes and cancer cells responsible for tumor growth.

Teva's Granix Injection has been approved by the FDA for self-administration by patients and caregivers.

Raulo Frear, PharmD, general manager of OmedaRx, discusses the high initial cost of hepatitis C drugs like Sovaldi compared with the long term cost of treating the disease.

Carfilzomib added to 2-drug combination produces longer remission period.

Experimental treatment effective in melanoma patients resistant to drugs that target BRAF.

Baxter International Inc has submitted a biologics license application to the FDA for the approval of BAX111, the first highly purified recombinant von Willebrand factor in clinical development as a treatment for von Willebrand disease.

Adding a building block found in DNA could aid healthy cell production in cancer patients, study finds.

Study finds drawing blood can be a powerful therapeutic in extracorporeal photopherisis.

Among hospital staff, pharmacists report better health behaviors and more participation in workplace health promotion activities than nurses.

Purchasing and distributing supplies traditionally accounts for less than half of a health system's operating costs. Over time, that proportion has increased, necessitating optimization of product distribution systems.

Many patients do not fully understand the risks of unnecessary antibiotic prescribing.

Combinations of drugs already approved found to be safe in treatment of rare disease.

Vaccine therapy stimulates immune defenses.

Tips and statistics surrounding the challenge of medication adherence.

Study suggests drug has negative impact on immune system.

Pharmacists charged with distributing tainted drugs that caused a fungal meningitis outbreak that killed 64 individuals.

A new study has revealed that many patients infected with the hepatitis C virus do not seek treatment and become lost in the different stages of health care to manage the disease.

Multi-year agreement with AbbVie will place new drug as the exclusive option for patients with hepatitis C genotype 1.

Patients who received brentuximab vedotin post-transplant lived longer without disease progression than those on supportive care.

Study finds doctors shift health care services to Medicare when they can profit from doing so.

A bill to make pharmacy benefit managers' reimbursements for generic drugs more transparent will cover more federal health care programs than a bill introduced earlier this year.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developing trends in copay and reimbursement assistance that specialty pharmacies need to be aware of.

One important reason for maintenance of Saturday delivery by the United States Postal Service was the importance of weekend delivery in the supply of medications through mail-order pharmacies.

Olaparib (Lynparza) was approved with companion diagnostic that detects mutations in BRCA genes.

Nivolumab treats patients with unresectable or metastatic melanoma who no longer respond to other drugs.

Data for daclatasvir not suitable to prove added benefit.

Related study shows satisfied specialty pharmacy members more likely to be adherent to their biologic anti-inflammatory medicines.

Lanreotide is first antitumor drug to show statistically significant progression-free survival in patients with gastrointestinal and pancreatic tumors.

The FDA today approved ombitasvir, paritaprevir, and ritonavir tablets copackaged with dasabuvir tablets to treat individuals with chronic hepatitis C virus genotype 1 infection, including patients with cirrhosis.

Olaparib treats women with advanced ovarian cancer associated with defective BRCA genes.